Rheumatoid Arthritis Completed Phase 4 Trials for Leflunomide (DB01097)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00280644Leflunomide in Rheumatoid ArthritisTreatment
NCT00451971Objective Study in Rheumatoid ArthritisTreatment
NCT01172639Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.Treatment
NCT02644499Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid ArthritisTreatment
NCT00422227Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific RegionTreatment
NCT00563849Leflunomide + Methotrexate in Rheumatoid ArthritisTreatment